EPO and hemosiderosis: This finding, along with the consideration that the guidelines issued by the Brazilian Ministry of Health ban the use of EPO when percent transferrin saturation is less than 25% even when ferritin levels are above 500 ng/dL, raises questions over the recommendations in effect and may open room for a review of the Brazilian guidelines, since overprescription of iron therapy may lead to hemosiderosis.